AAV vector biology in primates: Finding the missing link?

Molecular Therapy

Volumn 19, Issue 11, 2011, Pages 1923-1924

  Herzog, Roland W ^d   Davidoff, Andrew M ^a   Markusic, David M ^b   Nathwani, Amit C ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; VIRUS ANTIBODY;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 8; ANTIBODY PRODUCTION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; GENE EXPRESSION; GENE TRANSFER; GENETIC DISORDER; HEMOPHILIA B; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; METABOLIC DISORDER; MOLECULAR BIOLOGY; NONHUMAN; PRIMATE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

PRIMATES;

EID: 80455168205     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.218     Document Type: Editorial

References (13)

1. High, KA (2011). Gene therapy for haemophilia: a long and winding road. J Thromb Haemost 9 (suppl. 1): 2-11.
2. Ponder, KP (2011). Hemophilia gene therapy: a Holy Grail found. Mol Ther 19: 427-428.
3. Herzog, RW (2007). Immune responses to AAV capsid: are mice not humans after all? Mol Ther 15: 649-650. (Pubitemid 46431983)
4. Li, H, Lasaro, MO, Jia, B, Lin, SW, Haut, LH, High, KA et al. (2011). Capsid-specifc T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther 19: 2021-2030.
5. Nietupski, JB, Hurlbut, GD, Ziegler, RJ, Chu, Q, Hodges, BL, Ashe, KM et al. (2011). Systemic administration of AAV8-a-galactosidase A induces humoral tolerance in nonhuman primates despite low hepatic expression. Mol Ther 19: 1999-2011.
6. Wang, L, Bell, P, Lin, J, Calcedo, R, Tarantal, AF and Wilson, JM (2011). AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta). Mol Ther 19: 2012-2020.
7. Mattar, CNZ, Nathwani, AC, Waddington, SN, Dighe, N, Kaeppel, C, Nowrouzi, A et al. (2011). Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques. Mol Ther 19: 1950-1960.
8. Hurlbut, GD, Ziegler, RJ, Nietupski, JB, Foley, JW, Woodworth, LA, Meyers, E et al. (2010). Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy. Mol Ther 18: 1983-1994.
9. Wang, L, Calcedo, R, Wang, H, Bell, P, Grant, R, Vandenberghe, LH et al. (2010). The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques. Mol Ther 18: 126-134.
10. Nathwani, AC, Gray, JT, McIntosh, J, Ng, CYC, Zhou, J, Spence, S et al. (2007). Safe and effcient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood 109: 1414-1421. (Pubitemid 46239572)
11. Nathwani, AC, Rosales, C, McIntosh, J, Rastegarlari, G, Nathwani, D, Raj, D et al. (2011). Long-term safety and effcacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins. Mol Ther 19: 876-885.
12. Calcedo, R, Morizono, H, Wang, L, McCarter, R, He, J, Jones, D et al. (2011). Adeno-associated virus antibody profles in newborns, children and adolescents. Clin Vaccine Immunol 18: 1586-1588.
13. Herzog, RW (2010). Hepatic AAV gene transfer and the immune system: friends or foes? Mol Ther 18: 1063-1066.